Holdings of iShares Genomics Immunology and Healthcare ETF
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 160.5M $ including 152.6M $ in equities, 95.1 %
- Positions
- 50 in 12 countries
- Top ten
- 46.8 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Revolution Medicines Inc | 76,325 | 11M $ | 6.85 % |
| 2 | Moderna Inc | 219,441 | 10.1M $ | 6.28 % |
| 3 | Ipsen SA | 42,810 | 8.4M $ | 5.24 % |
| 4 | Bayer AG | 156,689 | 7M $ | 4.38 % |
| 5 | Takeda Pharmaceutical Co Ltd | 202,500 | 6.8M $ | 4.22 % |
| 6 | Merck & Co Inc | 60,956 | 6.7M $ | 4.15 % |
| 7 | GSK PLC | 252,397 | 6.6M $ | 4.12 % |
| 8 | Roche Holding AG | 15,724 | 6.4M $ | 3.99 % |
| 9 | Exelixis Inc | 137,027 | 6.1M $ | 3.80 % |
| 10 | Twist Bioscience Corp | 103,936 | 6.1M $ | 3.79 % |
| 11 | Regeneron Pharmaceuticals, Inc. | 8,462 | 6M $ | 3.73 % |
| 12 | Sanofi SA | 61,394 | 5.7M $ | 3.58 % |
| 13 | Vertex Pharmaceuticals Inc | 13,345 | 5.7M $ | 3.55 % |
| 14 | Incyte Corp | 59,291 | 5.6M $ | 3.52 % |
| 15 | Genmab A/S | 19,182 | 5.1M $ | 3.16 % |
| 16 | Ideaya Biosciences Inc | 149,434 | 4.3M $ | 2.71 % |
| 17 | ImmunityBio Inc | 589,940 | 4.2M $ | 2.61 % |
| 18 | Caris Life Sciences Inc | 205,671 | 3.9M $ | 2.44 % |
| 19 | Arcus Biosciences Inc | 133,599 | 3.4M $ | 2.12 % |
| 20 | Ono Pharmaceutical Co Ltd | 202,300 | 3M $ | 1.86 % |
| 21 | CRISPR Therapeutics AG | 55,336 | 2.9M $ | 1.80 % |
| 22 | Novavax Inc | 264,512 | 2.1M $ | 1.31 % |
| 23 | Iovance Biotherapeutics Inc | 593,884 | 2M $ | 1.24 % |
| 24 | GenFleet Therapeutics Shanghai Inc | 345,600 | 1.9M $ | 1.20 % |
| 25 | Nuvation Bio Inc | 426,642 | 1.9M $ | 1.18 % |
| 26 | Vir Biotechnology Inc | 167,572 | 1.7M $ | 1.07 % |
| 27 | AbCellera Biologics Inc | 411,289 | 1.7M $ | 1.06 % |
| 28 | Corvus Pharmaceuticals Inc | 102,168 | 1.6M $ | 0.97 % |
| 29 | Janux Therapeutics Inc | 95,943 | 1.4M $ | 0.86 % |
| 30 | Kura Oncology Inc | 150,470 | 1.3M $ | 0.83 % |
| 31 | Sunshine Lake Pharma Co Ltd | 190,700 | 1M $ | 0.62 % |
| 32 | CytomX Therapeutics Inc | 228,039 | 962.3K $ | 0.60 % |
| 33 | Ocugen Inc | 548,690 | 949.2K $ | 0.59 % |
| 34 | Rigel Pharmaceuticals Inc | 31,513 | 910.7K $ | 0.57 % |
| 35 | AbClon Inc. | 27,030 | 903.7K $ | 0.56 % |
| 36 | Intellia Therapeutics Inc | 66,593 | 897.7K $ | 0.56 % |
| 37 | Shanghai Henlius Biotech Inc | 83,900 | 805.6K $ | 0.50 % |
| 38 | Pacific Biosciences of California Inc | 483,024 | 768K $ | 0.48 % |
| 39 | Design Therapeutics Inc | 55,761 | 758.3K $ | 0.47 % |
| 40 | Valneva SE | 258,253 | 705.4K $ | 0.44 % |
| 41 | Ginkgo Bioworks Holdings Inc | 75,293 | 637K $ | 0.40 % |
| 42 | Verastem Inc | 116,276 | 634.9K $ | 0.40 % |
| 43 | Alvotech SA | 188,379 | 629.2K $ | 0.39 % |
| 44 | Personalis Inc | 94,670 | 522.6K $ | 0.33 % |
| 45 | Xencor Inc | 40,644 | 484.9K $ | 0.30 % |
| 46 | Guangzhou Innogen Pharmaceutical Group Co Ltd | 120,200 | 214.8K $ | 0.13 % |
| 47 | Prime Medicine Inc | 56,846 | 201.5K $ | 0.13 % |
| 48 | ARCELLX INC CVR | 73,059 | 5.1K $ | 0.00 % |
| 49 | OmniAb Inc | 19,498 | 0.2 $ | |
| 50 | OmniAb Inc | 19,498 | 0.2 $ |
Sector breakdown
- Health care 43.7 %
- Unattributed 56.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 64.2 %
- EUR 14.3 %
- JPY 6.4 %
- GBP 4.3 %
- CHF 4.2 %
- DKK 3.3 %
- HKD 2.6 %
- KRW 0.6 %
The quoted currency of each line, as declared.
Country breakdown
- United States 60.8 %
- France 9.7 %
- Japan 6.4 %
- Switzerland 6.1 %
- Germany 4.6 %
- United Kingdom 4.3 %
- Denmark 3.3 %
- Hong Kong SAR China 1.9 %
- Canada 1.1 %
- China 0.7 %
- South Korea 0.6 %
- Iceland 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 33 | 92.8M $ | 60.80 % |
| 2 | France | 3 | 14.9M $ | 9.74 % |
| 3 | Japan | 2 | 9.8M $ | 6.40 % |
| 4 | Switzerland | 2 | 9.3M $ | 6.10 % |
| 5 | Germany | 1 | 7M $ | 4.60 % |
| 6 | United Kingdom | 1 | 6.6M $ | 4.34 % |
| 7 | Denmark | 1 | 5.1M $ | 3.33 % |
| 8 | Hong Kong SAR China | 2 | 2.9M $ | 1.92 % |
| 9 | Canada | 1 | 1.7M $ | 1.12 % |
| 10 | China | 2 | 1M $ | 0.67 % |
| 11 | South Korea | 1 | 903.7K $ | 0.59 % |
| 12 | Iceland | 1 | 629.2K $ | 0.41 % |
Cite this page
Titelia. "Holdings of iShares Genomics Immunology and Healthcare ETF". https://titelia.com/en/funds/S000065599